Initial Management of Dysphagia in Polymyalgia Rheumatica (PMR)
For patients with PMR who develop dysphagia, specialist referral is strongly recommended for proper evaluation and management of the swallowing dysfunction, while continuing appropriate glucocorticoid therapy for the underlying PMR.
Evaluation of Dysphagia in PMR
When a patient with PMR presents with dysphagia, a structured approach is needed:
Determine if dysphagia is related to PMR or a separate condition:
- Consider if symptoms developed with PMR onset or worsened with PMR flares
- Evaluate for giant cell arteritis (GCA), which can occur with PMR and affect swallowing
- Rule out other causes of dysphagia (neurological, structural, medication-related)
Instrumental assessment of swallowing function:
- Videofluoroscopy (VFS) or Flexible Endoscopic Evaluation of Swallowing (FEES) should be performed to assess swallowing mechanics 1
- These studies can guide texture modifications and swallowing strategies
Management Algorithm
Step 1: Optimize PMR Treatment
- Ensure adequate glucocorticoid therapy for PMR according to guidelines:
- Initial prednisone dose of 12.5-25 mg daily (individualized based on disease severity and comorbidities) 1
- Monitor for clinical response of both PMR symptoms and dysphagia
- If dysphagia improves with PMR treatment, continue standard PMR management
Step 2: Implement Swallowing Modifications
For persistent dysphagia despite PMR treatment:
Dietary modifications:
Swallowing techniques:
Step 3: Specialist Consultation
- Speech-language pathology referral for structured assessment and rehabilitation 2
- Gastroenterology consultation if esophageal dysphagia is suspected 2, 3
- Rheumatology referral for patients with:
- Atypical PMR presentation
- Refractory symptoms
- Suspected giant cell arteritis 1
Special Considerations
Warning Signs Requiring Urgent Evaluation
- Weight loss
- Aspiration pneumonia
- Progressive worsening despite treatment
- Symptoms suggesting GCA (headache, vision changes, jaw claudication)
Pitfalls to Avoid
Misattributing dysphagia solely to PMR without proper evaluation - dysphagia is not a typical PMR symptom and may indicate:
- Concomitant GCA
- Separate neurological disorder
- Medication side effect
- Structural esophageal pathology 3
Inadequate glucocorticoid dosing - underdosing may fail to control inflammation if dysphagia is related to PMR/GCA 1
Delayed specialist referral - early evaluation by speech pathology and appropriate specialists improves outcomes 2
Monitoring and Follow-up
- Regular assessment of swallowing function
- Monitor nutritional status and weight
- Adjust PMR treatment according to disease activity
- Follow up with specialists as needed
By following this approach, clinicians can effectively manage dysphagia in patients with PMR while addressing both the underlying inflammatory condition and the specific swallowing dysfunction.